Metabolites increased and decreased by drought stress. by Yuanjie Weng (19193658)

FigureS4 from Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study) by Fanny Garlan (3153183)

Supplementary figure S1 from Periostin (POSTN) Regulates Tumor Resistance to Antiangiogenic Therapy in Glioma Models by Soon Young Park (14978769)

FigureS3 from Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study) by Fanny Garlan (3153183)

Cabozantinib treatment decreased microvessel density, but not proliferation and increased hypoxic stress in LuCaP 93 and LuCaP 173.1 patient-derived xenografts. by Mark P. Labrecque (10011469)

Supplementary Figure 1 from Inhibition of Sphingosine Phosphate Receptor 1 Signaling Enhances the Efficacy of VEGF Receptor Inhibition by Anthony S. Fischl (15070804)

Figure 7 from Single-Cell RNA Sequencing before and after Light Chain Escape Reveals Intrapatient Multiple Myeloma Subpopulations with Divergent Osteolytic Gene Expression by Denis Ohlstrom (15030192)

FIGURE 3 from Siglec-15 Promotes Evasion of Adaptive Immunity in B-cell Acute Lymphoblastic Leukemia by Claire E. Pillsbury (16435223)

Figure 2 from Targeting PRMT1 Reduces Cancer Persistence and Tumor Relapse in <i>EGFR</i>- and <i>KRAS</i>-Mutant Lung Cancer by Xiaoxiao Sun (20589448)

Supplementary Data from HDAC8 Regulates a Stress Response Pathway in Melanoma to Mediate Escape from BRAF Inhibitor Therapy by Michael F. Emmons (14935638)

Low ATF3 expression is associated with decreased survival and EZH2 and ATF3 signatures inversely correlate in human prostate cancers. by Amy E. Schade (15368259)

Subjects:

Figure 3 from ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Nab-Paclitaxel in Patients with Advanced Solid Tumors by Christopher T. Chen (19665314)

SRC-3 treatment decreased tumor growth in a Jeko-1 ibrutinib resistant mouse model. by Imani Bijou (18275174)

Related Article from Myeloid Suppressors Decrease Melanoma Survival by Abating Tumor-Fighting T Cells by Rolf Kiessling (149724)

Stability of the Arginine–Ornithine–Citrulline Cycle Maintained by Tumor–Stroma Interactions in Cell Coculture Hydrogel Microspheres by Hongren Yao (8857088)

“…In addition, an interesting phenomenon was discovered; in the absence of fibroblasts, the metabolism of the tumor cell culture alone leads to arginine depletion and citrulline accumulation, whereas a coculture can maintain the arginine–ornithine–citrulline cycle to reach equilibrium after 72 h, and the balance increases the stress resistance of tumor cells. …”

Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…</p>Methods<p>Publications from 1 January 2013 to 31 December 2023 that described clinical research of AGs were identified by searching the Web of Science Core Collection Database. …”

Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…</p>Methods<p>Publications from 1 January 2013 to 31 December 2023 that described clinical research of AGs were identified by searching the Web of Science Core Collection Database. …”

Figure 7 from MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer by Nami Yamashita (15100557)

“…<p>MUC1 and PBRM1 associate with decreases in responsiveness of TNBC tumors to chemotherapy. …”

Figure 6 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin by Joanna Domagala (21643925)

Figure 2 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin by Joanna Domagala (21643925)